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Introduction. Provoked vestibulodynia (PVD), a recurrent, localized vulvo-vaginal pain 
problem, carries a significant psychosexual burden for afflicted women, who report impoverished 
sexual function, and decreased frequency of sexual activity and pleasure. Interpersonal factors such as 
partner responses to pain, partner distress, and attachment style are associated with pain outcomes for 
women, and sexuality outcomes for both women and partners. Despite these findings, no treatment for 
PVD has systematically included the partner. 
Aims. This study pilot-tested the feasibility and potential efficacy of a novel cognitive-behavioral 
couple therapy (CBCT) for couples coping with PVD.  
Methods. Couples (women and their partners) in which the woman was diagnosed with PVD (n=9) 
took part in a 12-session, manualized CBCT intervention and completed outcome measures pre- and 
post-treatment.  
Main Outcome Measures. The primary outcome measure was women’s pain intensity during 
intercourse using a numerical rating scale. Secondary outcomes included sexual functioning and 
satisfaction for both partners. Exploratory outcomes included pain-related cognitions, psychological 
outcomes, and treatment satisfaction, feasibility and reliability. 
Results. One couple separated before the end of therapy. Paired t-test comparisons involving the 
remaining 8 couples demonstrated significant improvements in women’s pain, and sexuality outcomes 
for both women and partners. Exploratory analyses indicated improvements in pain-related cognitions, 
as well as anxiety and depression symptoms for both members of the couple. Therapists’ reported high 
treatment reliability, and participating couples’ reported high participation rates and treatment 
satisfaction indicate adequate feasibility. 
Conclusions. Treatment outcomes along with treatment satisfaction ratings confirm the preliminary 
success of CBCT in reducing pain and psychosexual burden for women with PVD and their partners. 
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Further large-scale randomized controlled trials are necessary to examine the efficacy of CBCT 
compared to, and in conjunction with first-line biomedical interventions for PVD. 
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Vulvodynia, or idiopathic, recurrent vulvo-vaginal pain, has a prevalence of 4 to 28% [1-3]. 
Vulvo-vaginal pain, often misunderstood and potentially underreported [4], carries stigma for many 
women [5], and can have deleterious consequences for women’s sexual functioning and quality of life 
[6]. Provoked vestibulodynia (PVD), the most frequent form of vulvodynia among pre-menopausal 
women, is characterized as a recurrent, sharp or burning pain triggered by contact to the vulvar 
vestibule, such as during vaginal sexual intercourse [7]. Extending beyond the mechanics of sexual 
function, women with PVD also report decreased sexual satisfaction [8], and less positive sexual self-
schema [9]. Epidemiological research indicates that anxiety and depression symptoms are significantly 
more frequent as antecedent conditions and as consequences to vulvodynia, in comparison to healthy 
controls [10]. Both women with vulvodynia and their partners report increased rates of depressive 
symptoms relative to a control sample [11]. While these women do not report significant differences in 
relationship satisfaction when compared to control women [12], qualitative studies suggest that women 
with vulvodynia report that the pain can have a damaging effect on the couple’s relationship, and fear 
losing their partner because of the pain [13]. Recent research also highlights the significant positive 
correlation between intimacy and sexual function and satisfaction for women with PVD [14], and the 
influence of attachment styles on pain and sexuality outcomes for both women and partners [15]. 
Despite the growing evidence for the bidirectional associations between PVD and romantic relationship 
factors, current treatments typically focus solely on the woman, and no empirically-tested treatment has 
systematically included the partner. 
Fueled by a biopsychosocial, multidimensional understanding of pain, there is a recent increase in 
the number of studies that have examined cognitive, affective, and behavioral factors related to PVD, 
and their associations with sexuality outcomes in afflicted women and their partners. With regard to 
cognitive factors, increased woman-reported PVD pain, and negative pain attributions made by the 
partner, have been associated with increased partner psychological distress [16]. Pain attributions refer 
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to one’s personal theory or explanation for the pain. In this scenario, partners may be less likely 
to utilize healthy forms of coping and may feel more helpless in the face of their female 
partners’ pain. For example, higher use of partner internal and global attributions, or beliefs that the 
pain is a result of the woman’s responsibility and that it affects other areas of the partner’s life, were 
associated with lower couple satisfaction. Moreover, partners’ attributions that the pain was global and 
stable predicted lower partner sexual satisfaction [16]. Thus the meaning that partners give to the 
woman’s pain problem may impact partners’ adaptation to the pain. 
Among women with PVD, higher levels of pain-related catastrophizing and lower pain self-efficacy 
are significantly correlated with higher ratings of pain during sexual intercourse, while greater pain 
self-efficacy is associated with women’s improved sexual functioning [17]. Recent consideration of the 
impact of partner cognitive variables in the context of PVD has revealed that higher partner pain 
catastrophizing significantly contributes to the variance in women’s reported higher pain intensity [18]. 
For example, partner pain catastrophizing may be manifested by a partner’s belief that the woman’s 
PVD pain will never end, or that it may get worse. According to the Communal Coping Model, pain 
catastrophizing represents a coping strategy through which the individual uses communication about 
the pain to solicit support and attention from others [19], whereas pain self-efficacy refers to one’s 
belief in their ability to cope with and control the pain. These two cognitive factors may be associated 
with pain intensity and functioning by promoting or interfering with adaptive coping mechanisms.  
 Consistent with data from the chronic pain literature, a cross-sectional association between 
partner responses to the woman’s PVD-related pain and pain intensity during intercourse has been 
reported [20]. Moreover, cognitive pain-related variables, such as pain catastrophizing, have been 
shown to significantly mediate the relation between solicitous (attention and concern) partner pain 
responding and increased pain intensity for women [21]. Findings from a dyadic daily diary study 
showed that sexual functioning improved for women with PVD when they perceived higher facilitative 
(encourages adaptive coping), and lower solicitous (attention and concern) and negative (frustration 
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and anger) responses to pain from their male partners, and partners’ sexual functioning 
decreased when they responded to pain in a more solicitous and negative manner [22]. Further 
research into behavioral factors relevant to the couple’s navigation of the pain experience has 
demonstrated that higher sexual assertiveness in partners is associated with higher sexual functioning 
among women with PVD, while higher sexual assertiveness among women is related to increased 
sexual satisfaction in partners [15]. These results, taken together, highlight how romantic relationship 
factors may influence the pain and sexual outcomes of couples coping with PVD.  
Recent examination of the affective aspect of interpersonal factors related to PVD indicates that 
women’s ratings of higher relationship intimacy (self- and partner-perceived disclosure and 
responsiveness) is associated with better sexual functioning, and that higher sexual intimacy (self-
disclosure, perceived partner-disclosure and partner responsiveness relating to sexual activity) are 
associated with increased sexual satisfaction, sexual functioning, and pain self-efficacy [14]. In keeping 
with emotional disclosure being an important aspect of intimacy, couples with PVD demonstrating 
lower ambivalence over emotional expression report higher sexual satisfaction and sexual functioning, 
higher dyadic adjustment, and fewer depressive symptoms [23]. Couples unburdened by ambivalence 
when it comes to emotional expression may report increased functioning because of more optimal 
communication resources to address sexual negotiation, conflict resolution or problem-solving, and 
adjustments to their sexual repertoire.   
The couple’s interactions on cognitive, behavioral, and affective levels and their associations 
with the vulvo-vaginal pain, as well as their shared sexual experience, highlight several avenues for 
intervention. Despite this, no study has examined the efficacy of a treatment for PVD that 
systematically includes the partner. Inclusion of the partner may help target the related cognitive, 
affective and sexuality dimensions, in addition to pain intensity.   
Of the women with PVD who seek medical help, the first stop for answers and relief is often a 
primary care physician, and thus many treatments target the pain symptoms. Despite the wide variety 
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of treatment options, which range from localized interventions such as topical ointments, 
physical therapy, and surgery to systemic interventions such as tricyclic antidepressants [24], 
there is a dearth of prospective studies assessing their efficacy. Given the multifaceted nature of PVD’s 
etiology and impact, a treatment model that can target pain, as well as its associated psychological, 
sexual and relationship consequences may represent an advantageous addition to current treatment 
options for PVD. 
Cognitive behavioral therapy (CBT) consists of a useful framework through which one can 
understand the interplay of interpersonal factors, sexual functioning, and sexual dissatisfaction in 
women with PVD. A long-term follow-up of women with PVD who had participated in a randomized 
controlled trial comparing vestibulectomy, biofeedback, and group CBT revealed treatment gains that 
were maintained at 2.5 years for improvements in pain and sexual functioning [25]. When considering 
self-reported pain during intercourse, vestibulectomy did not outperform CBT at long-term follow-up, 
highlighting the efficacy of CBT, a less invasive intervention that aims to target pain symptoms as well 
as the psychological, sexual, and relational sequelae of PVD. Further, a randomized trial examining the 
efficacy of individual CBT for vulvodynia compared to a supportive psychotherapy demonstrated that 
CBT resulted in significantly greater improvement in pain severity and sexual function from pre- to 
post-treatment, with gains being maintained at one-year follow-up [26]. These results demonstrate the 
efficacy and tolerability of psychosocial interventions for PVD while also indicating the potential 
benefit for improved treatment outcome and patient satisfaction associated with a more directed 
psychological treatment approach. Traditionally, the woman diagnosed with PVD is treated on her 
own, representing a missed opportunity to target partner variables that can influence pain and sexuality 
outcomes for the woman, as well as partner outcomes. Repeated recommendations that a psychological 
intervention for PVD include the partner [27], along with a dearth of manualized interventions that can 
be tested and disseminated to clinicians, prompted the development of a cognitive-behavioral couple 




The goal of this study was to pilot test a novel, manualized, cognitive-behavioral couple 
therapy (CBCT) for women with PVD and their partners for initial effectiveness and feasibility. It was 
hypothesized that following CBCT, women would report significant pre- to post-treatment 
improvements in pain intensity experienced during intercourse, and that couples would report 
significant pre- to post-treatment increases in sexual functioning and satisfaction for both partners. In 
addition to these hypotheses, another goal of this pilot study was to conduct an exploratory examination 
of changes for women and partners’ pain self-efficacy, pain catastrophizing, relationship satisfaction, 
anxiety and depression. It was also hypothesized that couples would report strong treatment 
satisfaction, and that CBCT would demonstrate adequate feasibility and reliability measured by 
couples’ participation in interventions and homework exercises and therapists’ ability to administer 
planned interventions.  
Methods 
Participants 
Women diagnosed with PVD and their partners were recruited in two large metropolitan areas. Women 
(and their partners) were contacted using a databank of participants from other non-treatment studies 
from the authors’ laboratories, and couples who contacted these laboratories or who contacted 
collaborating health care professionals for information about ongoing research projects were also 
informed about this pilot study. Inclusion criteria for women with PVD were: (1) pain during 
intercourse which was reported as subjectively distressing and occurred at least during 80% of 
intercourse attempts, and had been present for at least one year; (2) pain limited to intercourse and 
other activities involving pressure to the vulvar vestibule; (3) significant pain in one or more locations 
of the vestibule during the gynecological examination, operationalized as a minimum average patient 
pain rating of 4 on a scale of 0 to 10; 4) a diagnosis of PVD following the gynecological examination; 
5) sexually active as a couple in the last three months (intercourse, manual, or oral stimulation); 6) in a 
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committed monogamous relationship with a partner for at least six months. Pain was assessed 
using the cotton-swab test, in which a cotton-swab is placed along the exterior or edge of the 
vestibule using point palpation. The authors’ research laboratories and collaborating physicians are 
familiar with this test, which has been standardized for research purposes. This procedure has been 
used successfully in previous research in the field, and demonstrates good inter-rater reliability between 
physicians [28]. PVD participants were excluded if: (1) vulvar pain was not clearly linked to 
intercourse or pressure applied to the vulvar vestibule; (2) one of the following was present: (a) major 
medical and/or psychiatric illness, (b) active infection, (c) deep dyspareunia, (d) vaginismus (as defined 
by Diagnostic and Statistical Manual of Mental Disorders-IV), (e) dermatologic lesion, (f) pregnancy 
or planning a pregnancy; (3) age less than 18 or greater than 45; (4) involved in ongoing couple 
therapy, and (5) currently being treated for PVD and unable/unwilling to cease treatment. Couples were 
also deemed ineligible if they did not live in the same city, and could not attend 12 weekly sessions, 
and if partners had: (1) a major medical and/or psychiatric illness, and (2) were less than 18 years of 
age. These eligibility criteria were chosen to ensure selection of a relatively homogeneous sample of 
sexually active couples in which the woman was suffering exclusively from PVD.  
Procedure 
The women and their partners were informed via telephone about the nature of the study, its 
anticipated schedule in terms of treatment and assessment, and the potential risks and benefits of 
participation. Across both research sites, a total of 39 women were approached and spoke directly with 
the research coordinator to receive information about the study. Of these, 10 were ineligible to 
participate for the following reasons: not currently partnered, no longer experiencing pain, currently 
pregnant, received an alternate diagnosis, currently living in separate cities, currently receiving 
treatment for PVD and unable/unwilling to cease this treatment, or currently undergoing 
psychotherapy, individually or as a couple. Of the remaining 29 eligible couples, 20 refused to 
participate. Reasons for refusal included: unable to make the time commitment, not currently interested 
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but may be in the future, not interested in treatment, not interested in couple therapy, and no 
longer interested in taking part in a research study. Couples who did not wish to participate 
were referred to other treatment resources if interested. Nine couples consented to participate, were 
scheduled for pre-treatment assessment, and began treatment immediately following pre-treatment 
assessment (31.0% acceptance).  
Intervention: Cognitive-behavioral couple therapy (CBCT) 
The CBCT intervention was delivered as 12 one-hour sessions. The treatment manual was adapted to 
reflect a similar content as that of Bergeron and colleagues’ empirically-tested cognitive-behavioral 
group therapy [29], with pertinent interventions added to reflect recent research regarding dyadic 
factors and PVD, and the incorporation of materials that emphasize the interpersonal dynamics of PVD. 
Overarching goals of the CBCT intervention were to enable couples to: (1) re-conceptualize PVD as a 
multidimensional pain problem influenced by a variety of factors including thoughts, emotions, 
behaviors, and couple interactions; (2) understand PVD as a couple problem in which both members 
affect and are affected by the pain; (3) identify and problem-solve about factors associated with pain 
during sexual activity with a view to increasing adaptive coping, for example, by increasing self-
efficacy and decreasing catastrophizing in each partner, with a goal to decrease pain intensity; (4) 
improve the quality of the couple’s sexual functioning using communication skills training, working on 
sexual approach and avoidance goals, and modifying the sexual script; (5) consolidate skills developed 
during the treatment. Examples of the specific CBCT interventions include psychoeducation about 
pain, communication skills training, discussion and expansion on the couple’s sexual narratives, 
mindfulness and cognitive defusion exercises, and pain journaling. Interventions were rooted in third 
generation cognitive-behavioral approaches, including an Acceptance and Commitment Therapy 
(ACT) approach, with an emphasis on engaging both partners, reducing experiential and behavioral 
avoidance, and identifying relevant relational patterns of the couple. A selection of the interventions 




Two therapists, one per site, were trained to use the CBCT manual. Each therapist 
underwent a training to familiarize themselves with the interventions, and worked with the manual’s 
authors to develop a detailed understanding of the interventions comprised in CBCT, as well as the 
rationale for each intervention. To help increase treatment-reliability, the CBCT manual’s interventions 
were structured and detailed, and included the empirical rationale behind the interventions. Therapists 
completed intervention checklists following each session to provide an indication of treatment 
reliability. Both therapists received weekly supervision from the CBCT manual’s senior authors (XX 
and XX). Sessions were DVD-recorded. This study was reviewed and approved by the XX Institutional 
Review Boards. All participants provided written informed consent. 
Outcome Measures  
Couples completed standardized self-report measures and took part in brief semi-structured interviews 
conducted by a research assistant pre- and post-treatment. The pre-treatment brief interview served to 
assess demographic information and pain history. The post-treatment interview was delivered to assess 
perceived progress, satisfaction with treatment, and invite couples to provide their feedback about the 
treatment.     
Main Outcome Measure - Pain 
Pain Intensity. Pain intensity during sexual intercourse was assessed using a numerical rating scale 
(NRS), ranging from 0 to 10, where 0 is no pain at all, and 10 is the worst pain ever, as recommended 
by the IMMPACT guidelines for chronic pain clinical trials [30]. This method for measuring pain has 
been shown to detect significant treatment effects in women with PVD and demonstrates a significant 
positive correlation with other pain intensity measures [31]. 
Quality of Pain. Vulvo-vaginal pain was also measured using the McGill Pain Questionnaire (MPQ; 
[32], a measure of the multidimensional aspects of the pain experience, including its sensory, affective 
and evaluative components. The MPQ is a widely used adjective checklist, which assesses both 
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qualitative and quantitative aspects of pain. The Pain Rating Index Total (PRI) scale was used, 
and demonstrated good internal consistency for the present sample (pre-treatment: ∝ = 0.81; 
post-treatment: ∝ = 0.88).  
Secondary Outcome Measures – Sexuality Outcomes for Women and Partners 
Sexual function. Sexual function was measured using the Derogatis Interview for Sexual Functioning - 
Self-Report (DISF-SR), a 25-item self-report version of a semi-structured interview designed to assess 
sexual function in both men and women [33]. It measures five dimensions of sexuality: sexual 
cognition/fantasy, sexual arousal, sexual behavior/experience, orgasm, and sexual drive/relationship. 
Scores can be calculated for each dimension and for global sexual functioning. The DISF-SR boasts 
good internal consistency and reliability, specifically with women experiencing sexual dysfunction . It 
was chosen because it can be administered to both women and men. In the present study, the 
coefficient alpha for women with PVD was 0.86 pre-treatment, and 0.91 post-treatment, and 0.87 and 
0.92 for partners.  
Sexual satisfaction. Sexual satisfaction was assessed using the Global Measure of Sexual Satisfaction 
Scale (GMSEX), which consists of 5 items assessing global sexual satisfaction. The GMSEX has high 
internal consistency and test-retest reliability [34]. The coefficient alpha for the present sample of 
women with PVD was 0.81 and 0.82, at pre-treatment and post-treatment respectively, and 0.56 and 
0.94 for partners. The irregular alpha coefficient for partners at pre-treatment may be a product of the 
small sample size in the present study.  
Exploratory Outcome Measures 
Pain catastrophizing. The Pain Catastrophizing Scale (PCS) is a 13-item scale that measures 
exaggerated negative perceptions and emotions regarding pain. Higher scores point to higher 
catastrophizing (range: 0-52). The PCS [35] has been tested for reliability and validity [36]. The partner 
version is also validated [37]. The PCS demonstrated good internal consistency in the present study 
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(pre-treatment for women and partners respectively: ∝ = 0.72 and 0.86; post-treatment: ∝ = 
0.91 and 0.88). 
Pain self-efficacy. Pain self-efficacy, or the pain patient’s belief in her capacity to cope and deal with 
the pain across different situations, was measured using the Painful Intercourse Self-Efficacy Scale 
(PISES). The PISES [38] is 20-item scale adapted from the Arthritis Self-Efficacy Scale [39]. The 
adapted version demonstrates identical factor structure to the original scale [38], for which reliability 
and validity have been established [39]. The partner version assesses the partner’s perception of the 
pain patient’s self-efficacy. The coefficient alpha for women in the present study was 0.64 pre-
treatment, and 0.71 post-treatment for women with PVD, and 0.83 and 0.92 for partners for pre- and 
post-treatment respectively.   
Relationship satisfaction. The 32-item version of the Couple Satisfaction Index (CSI) [40] was used to 
measure relationship satisfaction. Compared to other well-known relationship satisfaction measures 
(e.g., Dyadic Adjustment Scale [41]; and the Marital Adjustment Test [42]) it demonstrates strong 
convergent validity, and a higher precision and power for detecting distinctions in satisfaction levels. 
Moreover, unlike similar relationship satisfaction scales, the CSI has been tested with a sample of 
participants spanning the relationship spectrum (e.g., dating, engaged, married). The CSI demonstrated 
good internal consistency in the present study (pre-treatment for women and partners: ∝ = 0.97; post-
treatment: ∝ = 0.97).  
Anxiety. Anxiety was assessed using the Spielberger State-Trait Anxiety Inventory (STAI). The STAI 
[43] is a widely used 40-item measure of state and trait anxiety. The 20 items assessing trait anxiety 
was used for this study. Cronbach alpha scores for women in the present study were 0.86 and 0.86 at 
pre- and post-treatment, and 0.96 and 0.94 for partners.  
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Depression. The Beck Depression Inventory-II (BDI-II) was used to measure symptoms of 
depression. The BDI-II is comprised of 21 items, with scores for most items ranging from 0 
(low intensity) to 3 (high intensity) [44, 45]. This measure of depression has been validated for use in 
chronic pain populations [46]. In the present study, the small sample size resulted in irregular Cronbach 
alpha values for this measure, which otherwise demonstrates good internal consistency (pre-treatment 
for women and partners respectively: ∝ = 0.52 and 0.96; post-treatment: ∝ = 0.70 and 0.44). 
Participant ratings of global improvement. In order to measure the clinical significance of the findings 
and as recommended by IMMPACT guidelines [30], women with PVD and partners each rated 
perceived global improvements in pain and sexuality at post-treatment by selecting one of the 
following five options: Great improvement, moderate improvement, small improvement, no 
improvement, or deterioration.  
Treatment Satisfaction, Feasibility and Reliability 
At post-treatment, couples were asked to rate their satisfaction with the treatment on a NRS of 0 to10, 
with 0 being completely dissatisfied, and 10 being completely satisfied. Both members of the couple 
were also asked to each identify which components of the treatment they found most helpful, and least 
helpful. At each session, couples reported on completion of at-home interventions (i.e., homework), 
and therapists completed an intervention checklist for each session to indicate whether planned in-
session exercises were completed or not. If not, therapists indicated if time-overage occurred, and if the 
exercise could be conducted in the following session to help the authors improve the use of the 
treatment manual; time overages or interventions moved to following sessions were coded as not 
completed. Homework completion rates were determined based on homework completed during the 
week it was assigned; homework completed at a later time was not coded as completed. A treatment 
manual-reliability score was computed based on the number of planned interventions that were 




Treatment outcomes for primary and secondary outcomes – pain and sexuality measures – 
were determined by pre- and post-treatment differences calculated using two-tailed, paired-samples t-
tests for all outcome variables. All tests used a significance level of alpha = 0.05. Only parametric test 
results are presented given that Wilcoxon signed-rank tests were conducted to control for non-
normality, and yielded similar conclusions to paired-sample t-tests. General linear model (GLM) 
contrasts were conducted between sites for primary and secondary outcome variables. Original 
standard deviations were used to compute Cohen’s d, or effect size values, given the likelihood that 
pooled standard deviations are corrected for correlation between measures, and therefore yield 
overestimated values for effect size [47]. Effect sizes of 0.20, 0.50, and 0.80 or larger are respectively 
classified as small, medium, and large [48]. Exploratory analyses were conducted using percent change 
analyses of sample means for pain self-efficacy, pain catastrophizing, relationship satisfaction, anxiety, 
and depression. Treatment satisfaction, and treatment-manual reliability and homework completion 
scores were averaged across participants.  
Results 
Sample Characteristics 
Participants’ characteristics are displayed in Table 2. All recruited couples were heterosexual. The 
mean (M) age of women with PVD was 26.11 years (R = 19-35), and the average age of male partners 
was 28.44 years (R = 21-45). Couples had been in their relationship for an average of 4.4 years (SD = 
2.8), with the pain often pre-dating the relationship for an average pain history of 6.72 years (SD = 
4.16). The majority of the couples had post-secondary education (M = 16.17 years; SD = 2.46) and the 
sample was homogeneous in terms of ethnicity. While participants were asked not to use other 
treatments during their participation in this study, one participant saw a physical therapist twice during 
the course of the 12 sessions. Of the nine couples recruited, eight attended all 12 sessions of CBCT. 
One couple separated before completing all 12 sessions. This couple was not included in analyses. 
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Means and standard deviations for pain and sexuality outcomes are found in Table 3. 
Percent change values for exploratory variables are found in Table 4.  
Primary outcome (n=8) 
Pain. There was a significant decrease in pain during intercourse from pre- to post-treatment, t 
(7) = 3.89, P = 0.006, d = 2.05. No significant difference was found between sites (F1,6 = 1.433, P = 
0.276). Using the MPQ PRI Total score, there was also a significant decrease in women’s reported 
multidimensional aspects of pain, t (7) = 2.64, P = 0.034, d = 0.45, with no significant difference 
between sites (F1,6 = 0.68, P = 0.803).  
Secondary outcomes (n=8) 
Sexuality outcomes. From pre- to post-treatment, women with PVD reported significant 
improvements in sexual functioning, t (7) = -3.47, P = 0.010, d = 0.72, and sexual satisfaction, t (7) = -
3.06, P = 0.018, d = 1.28. There were no significant differences between sites (sexual function: F1,6 = 
0.323, P = 0.968; sexual satisfaction: F1,6 = 1.263, P = 0.304). Male partners also reported significant 
increases in sexual satisfaction, t (7) = -3.78, P = 0.007, d = 1.90, but increases in sexual functioning 
were not statistically significant, t (7) = -1.41, P = 0.202, d = 0.21. There was no significant difference 
in sexuality outcomes for partners between sites (sexual function: F1,6 = 1.473, P = 0.270; sexual 
satisfaction: F1,6 = 0.165, P = 0.699).   
Exploratory outcomes (n=8) 
Pain-related cognitions. In terms of pain-related factors, both women and partners 
demonstrated pre- to post-treatment decreases in pain catastrophizing (Women, 54.97% decrease, d = 
2.03; Partners, 58.33% decrease, d = 1.86), and both women and partner perceptions of women’s pain 
self-efficacy showed increases from pre- to post-treatment (Women, 23.64% increase, d = 1.69; 
Partners, 36.29% increase, d = 1.88).     
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Relationship satisfaction. Women and partners both reported small increases in 
relationship satisfaction following treatment (Women, 6.31% increase, d = 0.33; Partners, 
6.46% increase, d = 0.32). 
Psychological outcomes. Women reported decreased trait anxiety, 12.02% decrease, d = 0.69, 
and a large decrease in self-reported depression symptoms following treatment, 45.28% decrease, d = 
1.41. Male partners also reported a decrease in anxiety, 9.96% decrease, d = 0.32, and in depression 
symptoms, 50.77% decrease, d = 0.56. 
Participant ratings of global improvement. Across couples, 75% reported “moderate progress” to 
“complete resolution” of the woman’s pain following treatment. And for both women and partners, 
100% reported “moderate” to “a lot” of progress in their sexual life after taking part in treatment. 
Treatment Satisfaction, Feasibility and Reliability. In terms of treatment satisfaction, the mean rating 
from women was 9.0 out of 10 (SD = 1.20), and the mean partner rating was 9.13 (SD=1.13). Given 
that one couple did not complete treatment, the attrition rate was 11%. The average therapist-reported 
treatment manual reliability across all sessions was 89.8% (range 87.0 % to 99.0%). Women with PVD 
who completed all 12 sessions of treatment reported a mean of 64.8% for completion of at-home 
interventions (range 50.0% to 77.8%), and the average for male partners who completed all 12 sessions 
of treatment was 59.3% (range 28.6% to 76.9%). No adverse events occurred during the study. 
Interventions identified as most helpful or most liked included emotional disclosure and building 
(sexual) communication as part of communication skills training, the progressive approach of all 
interventions, sensate focus or shared sensual and non-sensual massage, and cognitive defusion 
exercises. Certain couples also reported that it was beneficial and appreciated that each session focused 
on both the woman and the partner. The interventions that were reported as least helpful or liked were 
pain journaling, mindfulness body scan, and PVD psychoeducation. Some couples reported that the 




This study aimed to pilot test the effectiveness of CBCT in improving pain and sexuality, as 
well as to explore its potential usefulness in addressing psychological outcomes associated 
with PVD in women and their partners. Results of the present preliminary study suggest that CBCT is a 
promising treatment option for couples experiencing PVD. All participants who completed the 12 
sessions of CBCT reported improvement across the targeted outcomes, and indicated high treatment 
satisfaction. 
          As hypothesized, there was a significant decrease in women’s pain intensity during sexual 
intercourse as measured using the NRS and the McGill Pain Questionnaire’s PRI. Specifically, women 
reported a 51% decrease in pain from pre- to post-treatment. The IMMPACT guidelines for clinical 
trials in chronic pain indicate that changes in self-reported pain of more than 30% from baseline on a 
NRS represent moderately important clinical differences [30], suggesting that the changes in the 
present sample are clinically significant. Further, all couples reported moderate improvement to 
complete resolution of the pain in the post-treatment interview. These results are consistent with or 
superior to those of previous treatment studies examining CBT interventions for PVD [26, 28]. Given 
the multidimensional aspect of pain, it is possible that CBCT contributed to reduce pain during 
intercourse by helping couples better understand its multifactorial aspects, develop a shared awareness 
of the thoughts, emotions and couple interactions that trigger and maintain it, and gradually become 
more efficient at managing this challenging experience together. For example, the pain-journaling 
coupled with newly acquired communication skills may have enabled couples to better navigate pain 
triggers, and problem-solve before or during a painful experience to reduce pain.    
 Women reported significant improvement in sexual functioning, and both members of the 
couple reported significant increases in sexual satisfaction. This significant increase in sexual 
functioning for women following treatment corroborates findings from previous treatment studies for 
PVD, which show that a CBT intervention contributes to improving sexual function [26, 28]. The 
increase in sexual functioning reported by partners was not significant, likely because partners did not 
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report difficulties with sexual functioning at pre-treatment. This is not surprising in light of 
the fact that the mean age of these men was 28 years. There was, however, a significant 
increase in sexual satisfaction for both women and partners at post-treatment, which highlights the 
subjective improvement in the couple’s shared sexuality following treatment. There are many factors 
that contribute to one’s subjective evaluation of his or her sexual experiences. A capacity to attend 
more to the eroticism and pleasure associated with their sexual activity may constitute one of the 
benefits of treating the couple together. Additionally, the focus CBCT places on mindfulness, sexual 
communication, expansion of the couple’s sexual narrative and building of their sexual repertoire may 
have helped participants develop more positive sexual experiences. This may have worked by 
decreasing distress related to previously unspoken needs, and increasing focus on the pleasure 
associated with sexual activity, rather than the pressure and premium often associated with the 
mechanics of sexual intercourse. This interpretation is consistent with McCarthy and Wald’s [49] 
premise that mindfulness and the encouragement of Good Enough Sex (e.g., lessened focus on erection 
maintenance and orgasm achievement as indicators of sexual success) help foster sexual desire and 
satisfaction, two key components of healthy sexuality for the couple [50].   
 The exploration of pre- to post-treatment changes in pain-related cognitions, relationship 
satisfaction, and psychological outcomes may contribute to elucidate other potential treatment gains of 
CBCT. Both members of the couple reported a large decrease in pain catastrophizing, which is the 
composite of rumination, magnification, and feelings of helplessness about the pain [35]. This 
improvement may derive from CBCT’s emphasis on facilitating validation and empathic understanding 
of each other’s experience of the pain that is fostered during therapy and for the couple. Targeting 
thoughts via cognitive defusion may be another mechanism by which couples’ view of the pain may 
begin to change. The Communal Coping Model of Pain posits that catastrophizing represents a form of 
coping by communicating one’s pain to another with the intention of increasing proximity and 
soliciting support and empathy [51]. Therefore, women and partners’ decrease in catastrophizing could 
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reflect the acquisition of new coping strategies developed during therapy, and a shift toward 
more adaptive ways of communicating support needs in relation to the pain. Similarly, 
women’s pain self-efficacy increased following treatment, as well as partners’ perceptions of women’s 
pain self-efficacy. As with the decrease in catastrophizing, an increase in pain self-efficacy may be 
indicative of the woman’s exposure to and development of proactive, approach strategies for coping 
with her pain, which could lead to a better sense of her capacity to manage the pain. Moreover, CBCT 
incorporates components of third generation cognitive-behavioral therapy such as ACT, a form of 
treatment that has been empirically demonstrated to help reduce pain and pain-related cognitive-
affective factors for patients with chronic pain [52]. 
 Although slight, relationship satisfaction for both women and partners showed improvement 
following treatment. This change is likely small because the couples in the current sample, on average, 
did not report clinically significant relationship distress at pre-treatment. While decreased relationship 
satisfaction has been associated with higher pain ratings for women with PVD [53], previous research 
has indicated that women with PVD generally do not report significantly different relationship 
satisfaction than controls [12]. 
 Moreover, women and partners reported an increase in psychological well-being as indicated by 
reductions in depression and anxiety. Viewing depression in its relation to helplessness [54], one can 
infer that CBCT offered support and hope to women with PVD. CBCT may have enabled women and 
partners to feel less alone through validation and normalization, helped enrich their understanding of 
the pain and its impact, as well as encouraged the development of more empathy towards themselves. 
This may have occurred, in part, by reducing negative feelings known to be associated with perceived 
pain intensity [55]. Therefore, CBCT may have modified negative attributions women and partners 
may have previously held about their pain, which have been previously associated with negative 
psychological and psychosexual outcomes for women with PVD [56]. Similarly, the decrease in 
depression and anxiety symptoms may stem from CBCT offering the couple tools to experience 
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closeness despite the pain, diminishing distress by fostering partner empathy for the spouse 
with pain [57], and to tackle the pain together, rather than viewing it as a burden for the 
woman to carry on her own. Through a third generation CBT framework, CBCT aimed to encourage 
acceptance of the pain problem, which can lead to positive pain and psychological outcomes for 
chronic pain patients [52]. Further examination of other distress indicators, such as sexual distress, and 
controlled investigation with larger samples are recommended to replicate this finding.  
 CBCT capitalizes on empirically established knowledge regarding the relationship factors that 
play important roles for couples experiencing PVD. Both members of the couple reported high 
treatment satisfaction ratings, as well as perceived improvement based on their experience in CBCT. It 
could be surmised that CBCT demonstrated a benefit for both partners because of the inherent nature of 
PVD’s negative impact on the couple’s shared sexuality. Previous work including the partner when 
targeting sexual and intimacy outcomes has yielded effective results for sexual desire problems among 
women and their partners [58, 59], for improving functioning among breast cancer patients and their 
partners [60], and for intimacy building among prostate cancer patients and their partners [61]. 
Acceptable homework completion rates and good therapist-reported treatment manual reliability 
suggest that CBCT can be considered an acceptable, well-received and feasible intervention for couples 
in which the woman is suffering from PVD. Comparison between sites showed no significant 
difference for primary and secondary outcomes, which implies a reliability of outcomes across sites. 
Despite several indicators of feasibility, recruitment for this treatment study yielded high participant 
refusal rates. While these rates may reflect a low preference for this couple-based therapy, high 
participant refusal rates may also be related to the recruitment of participants from previous research 
studies, rather than the use of advertising or clinical referrals meant to target treatment-seeking women 
and couples with PVD. More research is needed to shed light on this important issue. Nevertheless, 
given that CBCT demonstrates effectiveness in decreasing pain intensity, as well as improving sexual 
and psychosocial outcomes, it may represent a worthwhile concurrent or adjuvant treatment to current 
  
22 
medical and physical therapies for PVD, or a potential alternative treatment option for women 
and partners searching for a less invasive intervention with no physical side effects.  
 Pilot studies represent a first step, and as such, there are limitations to the conclusions that can 
be drawn from the present findings [62, 63]. First, the sample size was small, which limited the power 
and complexity of the statistical analyses used to detect treatment-related changes. Additionally, given 
the small sample size, internal consistency was irregular for certain measures, despite these measures’ 
previous validation and demonstration of excellent internal consistency among larger samples of the 
same population. Clinical implications of this pilot study may be limited because the present sample 
was comprised of couples that were sexually active throughout the duration of the treatment, which 
may not be representative of couples having ceased sexual activity due to the pain. The low acceptance 
rate of participation may represent a further limitation in regards to treatment uptake. This study did not 
include a control group, so it is not possible to know whether the observed changes in outcomes would 
have occurred with the passage of time, in the absence of active intervention. Moreover, only 
heterosexual couples were included in this study’s sample. Because participants were not randomized 
to CBCT, there is a possibility of a self-selection bias for couples in search of a therapeutic intervention 
for PVD. Lastly, , the reported treatment manual reliability may be biased by therapist self-reports. 
These limitations point to the importance of further testing of CBCT in a randomized clinical trial.  
Conclusions  
The present study represents a timely integration of the growing body of research highlighting 
the importance of dyadic factors related to PVD. These preliminary findings show successful treatment 
outcomes following 12 sessions of CBCT, not only for affected women, but also for their partners. This 
suggests that the inclusion of the partner in the treatment of PVD appears beneficial. Taken together 
with high treatment satisfaction ratings, the lack of adverse events, good treatment reliability ratings 
provided by therapists, and the high attendance rate, CBCT may represent a potential intervention to 
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reduce pain intensity during intercourse, as well as improve the sexual and psychosocial well-
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